Related Experiment Videos
Asthma in infants and small children
1Department of Pediatrics, National Jewish Center for Immunology and Respiratory Medicine, Denver, Colorado, USA.
Insights
Diagnosing and treating wheezing in infants requires specialized approaches. This guide covers differentiating asthma from bronchitis, safe medication use, inhalation therapies, and non-drug treatments for young children.
Area of Science:
- Pediatric Pulmonology
- Allergy and Immunology
- Clinical Therapeutics
Background:
- Wheezing in young children presents diagnostic and therapeutic challenges.
- Differentiating asthma from viral-induced wheezing (wheezy bronchitis) is crucial for appropriate management.
- Many standard asthma medications lack FDA approval for infants.
Purpose of the Study:
- To outline a diagnostic strategy for wheezing infants.
- To discuss specific treatment considerations for this age group.
- To review current therapeutic options, including pharmacologic and non-pharmacologic approaches.
Main Methods:
- Review of diagnostic criteria for pediatric asthma and wheezy bronchitis.
- Analysis of drug safety and efficacy data in infants.
- Evaluation of inhalation therapy techniques, including metered-dose inhalers with spacers.
- Discussion of inhaled corticosteroids and other asthma medications.
- Consideration of non-pharmacologic asthma management strategies.
Main Results:
- Clinical differentiation between asthma and wheezy bronchitis in infants can be difficult but has significant implications.
- Limited FDA-approved medications necessitate careful consideration of off-label use and alternative treatments.
- Inhalation therapy with spacers is a viable option for delivering medications.
- Inhaled corticosteroids are a cornerstone of asthma management, with established benefit-risk profiles.
- Non-pharmacologic interventions play a vital role in managing pediatric asthma.
Conclusions:
- A tailored approach is essential for managing wheezing in infants and young children.
- Careful diagnosis, appropriate medication selection, and effective delivery methods are key.
- Long-term outcomes for wheezing conditions in childhood warrant ongoing monitoring and management.
Abstract:
The wheezy young child is a particularly challenging patient to treat. This article focuses on a diagnostic approach and some of the treatment issues peculiar to this age group. Specifically addressed are (1) the problem of differentiating asthma from wheezy bronchitis in babies and the clinical implications of this; (2) general concepts of treating babies in whom many commonly used drugs are not FDA approved; (3) inhalation therapy, especially the use of metered-dose inhalers with spacers; (4) the standard asthma drugs and their beneficial and adverse effects, with particular reference to inhaled steroids; and (5) the nonpharmacologic management of asthma. A brief discussion of long-term outcome is also included.